Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial

Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial

BackgroundUnderstudied elderly patients comprise a large segment of high-risk patients with glioblastoma (GBM) that are challenging to treat. Tumor Treating Fields (TTFields) is a locoregional, noninvasive, antimitotic therapy delivering low-intensity, intermediate-frequency alternating electric fie...

Full description

Bibliographic Details
Main Authors: Zvi Ram, Chae-Yong Kim, Andreas F. Hottinger, Ahmed Idbaih, Garth Nicholas, Jay-Jiguang Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Oncology
Subjects:
elderly patients
newly diagnosed glioblastoma
TTFields
Tumor Treating Fields
phase 3 clinical trial
efficacy and safety
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.671972/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.671972/full

Similar Items